Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection
NCT07461337Phase 2Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prosthetic joint infection (PJI), sponsored by University of Calgary. Primary endpoint: Clinical response to phage therapy at 1 year. Planned start Mar 2026; status: not yet recruiting.
02
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT07461337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07461337.